278 related articles for article (PubMed ID: 1867175)
1. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective.
Gross WL; Schmitt WH; Csernok E
Am J Kidney Dis; 1991 Aug; 18(2):175-9. PubMed ID: 1867175
[TBL] [Abstract][Full Text] [Related]
2. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases.
Hauschild S; Schmitt WH; Csernok E; Flesch BK; Rautmann A; Gross WL
Adv Exp Med Biol; 1993; 336():245-51. PubMed ID: 8296613
[TBL] [Abstract][Full Text] [Related]
3. [Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects].
Csernok E; Gross WL
Z Rheumatol; 1995; 54(1):26-38. PubMed ID: 7725808
[TBL] [Abstract][Full Text] [Related]
4. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
5. Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides.
Csernok E; Schmitt WH; Ernst M; Bainton DF; Gross WL
Adv Exp Med Biol; 1993; 336():45-50. PubMed ID: 8296655
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis.
Daouk GH; Palsson R; Arnaout MA
Kidney Int; 1995 Jun; 47(6):1528-36. PubMed ID: 7643521
[TBL] [Abstract][Full Text] [Related]
7. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
[TBL] [Abstract][Full Text] [Related]
8. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
[TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA).
Selak S; Woodman RC; Fritzler MJ
Clin Exp Immunol; 2000 Dec; 122(3):493-8. PubMed ID: 11122260
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations.
Schultz DR; Tozman EC
Semin Arthritis Rheum; 1995 Dec; 25(3):143-59. PubMed ID: 8650585
[TBL] [Abstract][Full Text] [Related]
12. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
[TBL] [Abstract][Full Text] [Related]
13. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
Baslund B; Petersen J; Permin H; Wiik A; Wieslander J
J Immunol Methods; 1994 Oct; 175(2):215-25. PubMed ID: 7930650
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
[TBL] [Abstract][Full Text] [Related]
16. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
[TBL] [Abstract][Full Text] [Related]
17. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.
Muller Kobold AC; Kallenberg CG; Tervaert JW
Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683
[TBL] [Abstract][Full Text] [Related]
18. Incidence and disease associations of a proteinase 3-antineutrophil cytoplasmic antibody idiotype (5/7 Id) whose antiidiotype inhibits proteinase 3-antineutrophil cytoplasmic antibody antigen binding activity.
Strunz HP; Csernok E; Gross WL
Arthritis Rheum; 1997 Jan; 40(1):135-42. PubMed ID: 9008609
[TBL] [Abstract][Full Text] [Related]
19. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
Gross WL; Csernok E; Flesch BK
J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA.
Schönermarck U; Lamprecht P; Csernok E; Gross WL
Rheumatology (Oxford); 2001 Feb; 40(2):178-84. PubMed ID: 11257154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
